Market Overview:
The global glycomics/glycobiology market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for glycomics and glycobiology products in drug discovery and development, diagnostics, and other applications. Additionally, the growing focus on personalized medicine is also contributing to the growth of this market. However, factors such as high cost of instruments and lack of skilled professionals are restraining the growth of this market. The global glycomics/glycobiology market can be segmented by type into instruments, enzymes, reagents, kits, and others. The instruments segment is expected to account for the largest share in terms of revenue in 2018 owing to its growing demand for use in research activities related to glycobiology/glycomics across different regions worldwide.
Product Definition:
Glycomics is the study of the structure, function, and biology of carbohydrates (glycans) in biological systems. Glycobiology is a sub-discipline of glycomics that focuses specifically on the role of glycans in health and disease. The importance of glycomics/glycobiology lies in its ability to provide insight into many areas of biology, including cell signaling, immunology, cancerogenesis, and stem cell Biology.
Instruments:
Instruments are tools that are used for measuring and analyzing biological macromolecules such as proteins, nucleic acids, enzymes etc. They can be broadly classified into two categories - those that provide direct measures of biomolecules (for example; spectrophotometer) and those that indirectly measure them (for example; glycosidase assay). Glycosidase assays were the first indirect methods to be developed.
Enzymes:
Enzymes are proteins that act as catalysts and help in the chemical reactions. They are used for various applications such as research, biotechnology, clinical diagnosis, food industry and manufacturing of various products such as detergents & cosmetics. Enzymes find their application in almost all areas of life sciences including genetic testing due to their use in determining the molecular weights of proteins; they also play an important role during pregnancy to ensure proper development of baby’s organs.
Application Insights:
Drug discovery and development was the largest application segment in 2017. It is estimated to grow at a CAGR of XX% from 2018 to 2030 owing to increasing R&D investments by major players for the discovery of novel molecules with higher efficiency as drugs or enzymes replacements. Glycomics/glycobiology offers several advantages over other methods for drug discovery and development such as predictive modeling, high-throughput screening, and virtual screening that can be effectively used in combination with each other or alone depending upon the research question being addressed.
Diagnostics is expected to witness lucrative growth during the forecast period owing to rising prevalence of chronic diseases such as cancer, diabetes mellitus type 2 & 3, autoimmune disorders etcetera worldwide which calls for rapid diagnostic solutions leading towards better diagnosis at lower costs while improving patient outcomes along with reducing healthcare expenditure globally which will stimulate industry growth over next eight years till 2030 eventually driving glycomics/ glycobiology market size globally.
Regional Analysis:
North America dominated the global glycomics/glycobiology market in 2017. The presence of a large number of pharmaceutical and biopharmaceutical companies involved in drug discovery and development activities is one of the major factors responsible for its continued dominance over the forecast period. Moreover, increasing focus on pre-clinical studies coupled with high healthcare expenditure levels are some other factors contributing to its growth.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to rising investments by various organizations such as National Institutes of Health (U.S.), Wellcome Trust (UK), Chinese government, etc.
Growth Factors:
- Increasing demand for novel therapeutics and diagnostics: The global glycomics/glycobiology market is expected to grow at a CAGR of over 9% from 2016 to 2024, owing to the increasing demand for novel therapeutics and diagnostics. This is mainly due to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases.
- Growing R&D expenditure in the life sciences sector: The global glycomics/glycobiology market is also driven by the growing R&D expenditure in the life sciences sector. This is because glycomics offers great potential for biomarker discovery and drug development. For instance, monoclonal antibodies (mAbs) are increasingly being used as therapeutic agents owing to their specificity and high affinity towards their targets. However, these mAbs are expensive to produce as they require extensive screening and characterization processes. Hence, there is a growing need for efficient methods for large-scale production of mAbs which can be met by advancements in glycomics technology platforms
Scope Of The Report
Report Attributes
Report Details
Report Title
Glycomics/Glycobiology Market Research Report
By Type
Instruments, Enzymes, Reagents, Kits, Glycomics/Glycobiolog
By Application
Drug Discovery & Development, Diagnostics, Others
By Companies
ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, Takara Bio, Inc., Agilent Technologies, Bruker, Promega, Waters Corporation, R&D Systems, New England Biolabs, Merck KGaA, Glycomics/Glycobiolog
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Glycomics/Glycobiology Market Report Segments:
The global Glycomics/Glycobiology market is segmented on the basis of:
Types
Instruments, Enzymes, Reagents, Kits, Glycomics/Glycobiolog
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Discovery & Development, Diagnostics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ThermoFisher Scientific
- Danaher
- Shimadzu Corporation
- ProZyme
- Takara Bio, Inc.
- Agilent Technologies
- Bruker
- Promega
- Waters Corporation
- R&D Systems
- New England Biolabs
- Merck KGaA
- Glycomics/Glycobiolog
Highlights of The Glycomics/Glycobiology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instruments
- Enzymes
- Reagents
- Kits
- Glycomics/Glycobiolog
- By Application:
- Drug Discovery & Development
- Diagnostics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glycomics/Glycobiology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glycomics is the study of glycoproteins and glycoconjugates, which are complex molecules consisting of sugar and protein. Glycobiology is the study of how these molecules interact with each other and their role in health and disease.
Some of the key players operating in the glycomics/glycobiology market are ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, Takara Bio, Inc., Agilent Technologies, Bruker, Promega, Waters Corporation, R&D Systems, New England Biolabs, Merck KGaA, Glycomics/Glycobiolog.
The glycomics/glycobiology market is expected to register a CAGR of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Glycomics/Glycobiology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Glycomics/Glycobiology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Glycomics/Glycobiology Market - Supply Chain
4.5. Global Glycomics/Glycobiology Market Forecast
4.5.1. Glycomics/Glycobiology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Glycomics/Glycobiology Market Size (000 Units) and Y-o-Y Growth
4.5.3. Glycomics/Glycobiology Market Absolute $ Opportunity
5. Global Glycomics/Glycobiology Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Glycomics/Glycobiology Market Size and Volume Forecast by Type
5.3.1. Instruments
5.3.2. Enzymes
5.3.3. Reagents
5.3.4. Kits
5.3.5. Glycomics/Glycobiolog
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Glycomics/Glycobiology Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Glycomics/Glycobiology Market Size and Volume Forecast by Application
6.3.1. Drug Discovery & Development
6.3.2. Diagnostics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Glycomics/Glycobiology Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Glycomics/Glycobiology Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Glycomics/Glycobiology Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Glycomics/Glycobiology Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Glycomics/Glycobiology Demand Share Forecast, 2019-2026
9. North America Glycomics/Glycobiology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Glycomics/Glycobiology Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Glycomics/Glycobiology Market Size and Volume Forecast by Application
9.4.1. Drug Discovery & Development
9.4.2. Diagnostics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Glycomics/Glycobiology Market Size and Volume Forecast by Type
9.7.1. Instruments
9.7.2. Enzymes
9.7.3. Reagents
9.7.4. Kits
9.7.5. Glycomics/Glycobiolog
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Glycomics/Glycobiology Demand Share Forecast, 2019-2026
10. Latin America Glycomics/Glycobiology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Glycomics/Glycobiology Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Glycomics/Glycobiology Market Size and Volume Forecast by Application
10.4.1. Drug Discovery & Development
10.4.2. Diagnostics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Glycomics/Glycobiology Market Size and Volume Forecast by Type
10.7.1. Instruments
10.7.2. Enzymes
10.7.3. Reagents
10.7.4. Kits
10.7.5. Glycomics/Glycobiolog
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Glycomics/Glycobiology Demand Share Forecast, 2019-2026
11. Europe Glycomics/Glycobiology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Glycomics/Glycobiology Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Glycomics/Glycobiology Market Size and Volume Forecast by Application
11.4.1. Drug Discovery & Development
11.4.2. Diagnostics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Glycomics/Glycobiology Market Size and Volume Forecast by Type
11.7.1. Instruments
11.7.2. Enzymes
11.7.3. Reagents
11.7.4. Kits
11.7.5. Glycomics/Glycobiolog
11.8. Basis Point Share (BS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Glycomics/Glycobiology Demand Share, 2019-2026
12. Asia Pacific Glycomics/Glycobiology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Glycomics/Glycobiology Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Glycomics/Glycobiology Market Size and Volume Forecast by Application
12.4.1. Drug Discovery & Development
12.4.2. Diagnostics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Glycomics/Glycobiology Market Size and Volume Forecast by Type
12.7.1. Instruments
12.7.2. Enzymes
12.7.3. Reagents
12.7.4. Kits
12.7.5. Glycomics/Glycobiolog
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Glycomics/Glycobiology Demand Share, 2019-2026
13. Middle East & Africa Glycomics/Glycobiology Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Glycomics/Glycobiology Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Glycomics/Glycobiology Market Size and Volume Forecast by Application
13.4.1. Drug Discovery & Development
13.4.2. Diagnostics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Glycomics/Glycobiology Market Size and Volume Forecast by Type
13.7.1. Instruments
13.7.2. Enzymes
13.7.3. Reagents
13.7.4. Kits
13.7.5. Glycomics/Glycobiolog
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Glycomics/Glycobiology Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Glycomics/Glycobiology Market: Market Share Analysis
14.2. Glycomics/Glycobiology Distributors and Customers
14.3. Glycomics/Glycobiology Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ThermoFisher Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Danaher
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Shimadzu Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ProZyme
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Takara Bio, Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Agilent Technologies
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bruker
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Promega
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Waters Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. R&D Systems
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. New England Biolabs
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Merck KGaA
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Glycomics/Glycobiolog
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
